Skip to main content

Advertisement

Log in

Length of Barrett’s segment predicts success of extensive endomucosal resection for eradication of Barrett’s esophagus with early neoplasia

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Although the efficacy and safety of extensive endomucosal resection (EMR) in eradicating Barrett’s esophagus (BE) harbouring early neoplasia have been established, factors predicting efficacy remains unclear.

Aim

To determine the complete eradication rate of Barrett’s esophagus with high-grade intraepithelial neoplasia (HGIN) or intramucosal carcinoma (IMC), safety, and factors predicting complete eradication by EMR.

Methods

Patients with histological confirmation of Barrett’s HGIN/IMC were prospectively identified. EMR was performed using Duette multiband ligator or cap technique by a single operator (NEM).

Results

99 patients (81 males) with median age 67 years [interquartile range (IQR) 60–77 years] and median Barrett’s length 4 cm (IQR 2–6 cm) were included. Of 628 index EMRs [mean 6.3, median 5 (IQR 3–8)], 23% showed IMC, 58.5% showed HGIN, and 16% showed low-grade dysplasia only. A median of 8 EMR resections per patient (IQR 6–16, 1,064 resections in 89 patients) resulted in complete eradication of BE harboring neoplasia in 49.4% and eradication of HGIN/IMC in 81% (BE <5 cm subgroup: 65% complete eradication and 91% HGIN eradication) at median follow-up of 18 months (range 6–27 months). On univariate analysis, focal dysplasia (P = 0.003) and Barrett’s length <5 cm (P = 0.001) were predictors of complete BE eradication. Barrett’s length <5 cm was the only significant predictor [odds ratio (OR) 3.4, standard error (SE) 0.11, P = 0.0006] on multiple logistic regression analysis. Strictures developed in 27% and major bleeding in 2% with no procedure-related perforations or mortality.

Conclusions

Extensive EMR for removal of BE with early neoplasia is safe. Outcomes for complete BE eradication are modest at 49.4% and eradication of high-grade dysplasia at 81%. Barrett’s length <5 cm is the only significant predictor of complete response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ferguson MK, Martin TR, Reeder LB et al (1997) Mortality after oesophagectomy: risk factor analysis. World J Surg 21(6):599–603

    Article  PubMed  CAS  Google Scholar 

  2. Reavis KM, Smith BR, Hinojosa MW, Nguyen NT (2008) Outcomes of esophagectomy at academic centers: an association between volume and outcome. Ann Surg 74(10):939–943

    Google Scholar 

  3. Nguyen NT, Hinojosa MW, Smith BR et al (2008) Minimally invasive oesophagectomy: lessons learnt from 104 operations. Ann Surg 248:1081–1091

    Article  PubMed  Google Scholar 

  4. Overholt BF, Wang KK, Burdick JS et al (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc 66:460–468

    Article  PubMed  Google Scholar 

  5. Barr H, Shepherd NA, Dix A et al (1996) Eradication of high-grade dysplasia in columnar lined (Barrett’s) oesophagus by photodynamic therapy by endogenously generated protoporphyrin IX. Lancet 348:584–585

    Article  PubMed  CAS  Google Scholar 

  6. Overholt BF, Panjehpour M, Heydek JM et al (1999) Photodynamic therapy for Barrett’s oesophagus: follow up in 100 patients. Gastrintest Endosc 49:1–7

    Article  CAS  Google Scholar 

  7. Shaheen NJ, Sharma P, Overholt BF et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Eng J Med 360:2277–2288

    Article  CAS  Google Scholar 

  8. Gondrie JJ, Pouw RE, Sondermeijer CM et al (2008) Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 40:370–379

    Article  PubMed  CAS  Google Scholar 

  9. Seewald S, Akaraviputh T, Seitz U et al (2003) Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to the management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57:854–859

    Article  PubMed  Google Scholar 

  10. Giovannini M, Bories E, Pesenti C et al (2004) Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36:782–787

    Article  PubMed  CAS  Google Scholar 

  11. Peters FP, Kara MA, Rosmolen WD et al (2006) Stepwise radial endoscopic resection is effective for complete removal, of Barrett’s oesophagus with early neoplasia. Am J Gastroenterol 101:1449–1457

    Article  PubMed  Google Scholar 

  12. Larghi A, Lightdale CJ, Ross AS et al (2007) Long-term follow up of complete Barrett’s eradication endoscopic mucosal resection for the treatment of high-grade dysplasia and intramucosal carcinoma. Endoscopy 39:1086–1091

    Article  PubMed  CAS  Google Scholar 

  13. Inoue H, Takeshita K, Hori H et al (1993) Endoscopic mucosal resection with a cap fitted panendoscope for esophagus, stomach and colon mucosal lesions. Gastrointest Endosc 39:58–62

    Article  PubMed  CAS  Google Scholar 

  14. Soehendra N, Binmoeller KF, Bohnacker S et al (1997) Endoscopic snare mucosectomy in the oesophagus without any additional equipment: a simple technique of resecting flat early cancer. Endoscopy 29:380–383

    Article  PubMed  CAS  Google Scholar 

  15. Schlempler RJ, Riddell RH, Kato Y et al (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47:251–255

    Article  Google Scholar 

  16. Nijhawan PK, Wang KK (2000) Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s oesophagus. Gastrointest Endosc 52:328–332

    Article  PubMed  CAS  Google Scholar 

  17. Buttar NS, Wang KK, Lutzke LS et al (2001) Combined endoscopic mucosal resection and photodynamic therapy for oesophageal neoplasia within Barrett’s oesophagus. Gastrointest Endosc 54:682–688

    PubMed  CAS  Google Scholar 

  18. Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57:1200–1206

    Article  PubMed  CAS  Google Scholar 

  19. May A, Gossner L, Pech O et al (2002) Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14:1085–1091

    Article  PubMed  Google Scholar 

  20. Ell C, May A, Gossner L et al (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s oesophagus. Gastroenterology 118:670–677

    Article  PubMed  CAS  Google Scholar 

  21. Pouw RE, Peters FB, Curvers LW et al (2007) Stepwise radial endoscopic resection for complete removal, of Barrett’s oesophagus with early neoplasia. A prospective study of 56 patients with 2 years follow up. Gastrointest Endosc 65:AB133 (Abstract)

    Article  Google Scholar 

  22. Gondrie JJ, Seewald S, Pouw ER et al (2008) Stepwise radical endoscopic resection for complete removal of Barrett’s esophagus with early neoplasia: international multicentre study. Gastrointest Endosc 67:AB175–AB176 (Abstract)

    Article  Google Scholar 

  23. Ormsby AH, Kilqore SP, Goldblum JR et al (2000) The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies. Implications for patient treatment and preventive strategies in Barrett’s oesophagus. Mod Pathol 13:614–620

    Article  PubMed  CAS  Google Scholar 

  24. Yachimski P, Puricelli WP, Nishioka NS (2008) Patient predictors of histopathologic response after photodynamic therapy of Barrett’s esophagus with high-grade dysplasia or intramucosal carcinoma. Gastrointst Endosc 69(2):205–212

    Article  Google Scholar 

  25. Kerkhof M, Van Dekken H, Steyerberg EW et al (2007) Grading of dysplasia in Barrett’s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 50:920–927

    Article  PubMed  CAS  Google Scholar 

  26. Levine DS, Haggitt RC, Blount PL et al (1993) An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s oesophagus. Gastroenterology 105:40–50

    PubMed  CAS  Google Scholar 

  27. Katada C, Muto M, Manabe T et al (2003) Esophageal stenosis after endoscopic mucosal resection of superficial oesophageal lesions. Gastrointest Endosc 57:165–169

    Article  PubMed  Google Scholar 

  28. Pech O, May A, Gunter E et al (2006) The impact of endscopic ultrasound and computerised tomography on the TNM staging of early cancer in Barrett’s oesophagus. Am J Gastroenterol 101:2223–2229

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. E. Marcon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, T., Ayaru, L., Lee, E.Y. et al. Length of Barrett’s segment predicts success of extensive endomucosal resection for eradication of Barrett’s esophagus with early neoplasia. Surg Endosc 25, 3627–3635 (2011). https://doi.org/10.1007/s00464-011-1769-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-011-1769-z

Keywords

Navigation